9999999997-23-003169.txt : 20230612 9999999997-23-003169.hdr.sgml : 20230612 20230612140002 ACCESSION NUMBER: 9999999997-23-003169 CONFORMED SUBMISSION TYPE: SEC STAFF ACTION CATEGORY: ORDER PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20230612 ACTION DATE: 20230612 RECEIVED DATE: 20230612 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Allena Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001624658 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 452729920 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SEC STAFF ACTION BUSINESS ADDRESS: STREET 1: 142 -F NORTH ROAD, SUITE 150 CITY: SUDBURY STATE: MA ZIP: 01776 BUSINESS PHONE: 617-467-4577 MAIL ADDRESS: STREET 1: 142 -F NORTH ROAD, SUITE 150 CITY: SUDBURY STATE: MA ZIP: 01776 ORDER 1 filename1.pdf begin 644 filename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end